• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » Wright Medical posts street-beating Q4, 2018 earnings

Wright Medical posts street-beating Q4, 2018 earnings

February 26, 2019 By Fink Densford

Wright Medical

Wright Medical (NSDQ:WMGI) today posted fourth quarter and full year 2018 earnings that beat expectations on Wall Street.

The Amsterdam-based company posted losses of approximately $33.8 million, or 27¢ per share, on sales of $238.1 million for the three months ended December 31, seeing a swing into red ink while sales grew 9.4% compared with the same period during the previous year.

After adjusting to exclude one-time items, earnings per share were 11¢, ahead of the 5¢ consensus on Wall Street, where analysts expected to see sales of approximately $237 million, which the company topped.

For the full year, Wright Medical posted losses of $169.5 million, or $1.51 per share, on sales of approximately $836.2 million, seeing losses shrink 16.3% while sales grew 12.2% compared with the previous year.

Adjusted to exclude one-time items, earnings per share were at 0¢, ahead of the 7¢ loss-per-share consensus on Wall Street, where analysts expected to see sales of $835 million, which the company topped.

“As previously reported, our fourth quarter results represent an outstanding performance across all our businesses.  This performance was driven by continued strong shoulder growth in the quarter, which included the ongoing launch of our Perform Reversed glenoid and continued contributions from our Simpliciti shoulder system.  We anticipate that these products, as well as accelerating adoption of our Blueprint enabling technology and the upcoming launch of our Revive revision shoulder system, will continue to drive strong shoulder sales growth in 2019 and beyond.  We also had strong adjusted EBITDA with 210 basis points of EBITDA margin expansion for the full-year and our adjusted gross margins of nearly 80% are some of the best in high-growth medtech. In our U.S. lower extremities business, we got off to a very strong start with Cartiva revenue of $9.5 million, which exceeded our expectations in the fourth quarter.  On January 1, Cartiva was fully launched with our U.S. lower extremities sales force, including the integration of the former Cartiva distributors that we have chosen to retain.  We also saw continued strong growth in our core products as well as in total ankle.  Our U.S. biologics business continued to be driven by the ongoing roll-out of Augment Injectable.  We intend to continue to focus on strong execution and new product launches throughout 2019,” prez & CEO Robert Palmisano said in a press release.

Wright Medical released guidance for the 2019 year, expecting to sales of between approximately $954 million and $966 million for the full year with non-GAAP adjusted EPS of between 17¢ and 25¢.

Shares in Wright Medical have stayed steady in after-hours trading after dropping approximately 4.2% today to close at $30.02.

Earlier this month, Wright Medical said that it inked a refinancing deal looking to exchange $112.1 million in existing 2% convertible senior notes due 2020 for $120.2 million in newly issued 1.625% senior notes due 2023.

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: wrightmedical

In case you missed it

  • 6 questions about facial swelling and COVID-19 vaccines answered
  • DTW Podcast Ep. 42 – How the pandemic has accelerated, slowed medtech innovation
  • The top 5 MassDevice stories of the week — January 22, 2021
  • Intuitive Surgical stock down despite Street-beating Q4
  • FDA says to limit mask decontamination to 4 cycles
  • 5 innovations to make duodenoscopes more single-use — and save lives
  • FDA approves Boston Scientific Vercise Genus deep brain stimulation system
  • Johnson & Johnson vaccine trial results expected soon
  • 7 takeaways from Biden’s ‘full-scale, wartime’ plan to combat the COVID-19 pandemic
  • Canon Medical large bore CT wins FDA clearance
  • Amazon offers to help Biden administration with vaccine distribution
  • Biden’s COVID-19 response will make manufacturers busy
  • Mylan must face EpiPen racketeering lawsuit
  • Boston Scientific to acquire Preventice Solutions
  • Obalon Therapeutics’ stock skyrockets after announcing ReShape Lifesciences merger
  • EmblemHealth to provide coverage for Senseonics’ Eversense CGM
  • Abbott’s MitraClip receives boost as CMS expands coverage for TMVR

RSS From Medical Design & Outsourcing

  • January 2021 Issue: The Leadership in Medical Technology Issue
    9 lessons in crisis management from Stryker CEO Kevin Lobo These 10 stories mattered the most for medtech in 2020 How ResMed is advancing sleep and respiratory care How Dexcom CEO Kevin Sayer is leading the company forward Black engineers group works to promote diversity in medtech, equity in healthcare Taking the guesswork out of… […]
  • Olympus recalls thousands of endo devices due to packaging defect
    Olympus is recalling approximately 26,000 disposable EndoTherapy devices because of a packaging defect that could compromise their sterility. The announcement affects113 models distributed in the U.S.since early 2019, with different numbers of SKUs available in different regions worldwide. The company is asking customers to quarantine the devices until they can be shipped back to Olympus.… […]
  • FDA says to limit mask decontamination to 4 cycles
    Soon after healthcare workers began warning of personal protective equipment (PPE) shortages, companies and other organizations started claiming their decontamination systems could reprocess used filtering facepiece respirators (FFRs) such as N95s up to 20 times. The FDA began issuing emergency use authorizations (EUAs) for FFR decontamination systems with a range of allowable cycles and major… […]
  • 5 innovations to make duodenoscopes more single-use — and save lives
    Duodenoscopes are important medical devices that are used for endoscopic retrograde cholangiopancreatography (ERCP) procedures. However, the devices have had serious problems in the past. Luckily, several medical device companies have stepped in to solve the problems. Duodenoscopes are flexible, lighted tubes threaded through the mouth, throat and stomach into the top of the small intestine.… […]
  • Plastic Molding Manufacturing adds 5 molding machines
    Plastic Molding Manufacturing (Hudson, Mass.) announced that it has added five new injection molding and two coordinate measuring machines in upgrades to its manufacturing and quality operations. The $1 million-plus investment will enable the custom molding company to distribute the pair of 214-ton machines, two 259-ton machines, and a 101-ton machine throughout its manufacturing network,… […]
  • CytoSorbents names former Integra exec to regulatory post
    Blood purification tech manufacturer CytoSorbents (NSDQ:CTSO)announced the appointment of David D. Cox as VP of global regulatory affairs. Cox was most recently VP of regulatory affairs for tissue and regenerative technologies at Integra LifeSciences (NSDQ:IART). He was responsible for regulatory approvals of new products and product extensions for the $480 million orthopedics and tissue technologies division.… […]
  • FDA clears Siemens’ radiography systems
    Siemens Healthineers (ETR: SHL) announced that the FDA has cleared its Multix Impact C ceiling-mounted digital radiography (DR) system as well as the Multix Impact VA20, a new version of the established floor-mounted parent DR system. The Multix Impact C and the Multix Impact VA20 were designed with an intuitive operating system, versatile wireless detectors, motorized tube… […]
  • 7 takeaways from Biden’s ‘full-scale, wartime’ plan to combat the COVID-19 pandemic
    President Joe Biden kept to his word to announce plans to “establish clear federal leadership” to tackle the coronavirus pandemic on his first full day in office. The White House issued a 200-page document on Inauguration Day detailing “full-scale, wartime” plans to harness the nation’s manufacturing and distribution capabilities to boost vaccine production, end shortages… […]
  • Qosina adds 12 new fluid and gas filters
    OEM single-use component supplier Qosina announced earlier this month that it added 12 new filter options for fluid and gas applications. Ronkonkoma, N.Y.-based Qosina’s filter product line includes offerings across a range of hydrophilic and hydrophobic filters, transducer protectors and an assortment of NRFit filters that are compliant with the ISO 80369-6 standard, according to… […]
  • OmniGuide launches surgical laser system fiber
    OmniGuide today announced the FDA clearance and commercial launch of its new OTO-U CO2 laser system fiber for use in ENT and otology surgery. The new fiber is designed to enable the surgeon to get into a tighter space with more precision and improve procedure outcomes, according to the Lexington, Mass.-based company. “OTO-U surgical fiber… […]
  • Biden’s COVID-19 response will make manufacturers busy
    Manufacturers of vaccine supplies and personal protective equipment can expect more work as the new Biden administration rolls out its “full-scale, wartime” plans to combat the COVID-19 pandemic. In one of his first official acts as president, Joe Biden announced a plan to “fully use” the Defense Production Act to ramp up manufacturing of testing… […]

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS